Overcome the main barriers to access diagnosis

Aligns with the United Nations Sustainable Development Goal 3 of the 2030 Agenda.
AFYIA's approach combines artificial intelligence, molecular biology and a rigorous industrial processes, resulting in easy-to-use products for human health with a high degree of reliability.
At AFYIA Diagnostics, research and development is at the heart of everything we do: we design innovative diagnostic solutions for infectious diseases from our laboratory in Grabels, in the south of France.











